Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-26T00:14:09.806Z Has data issue: false hasContentIssue false
  • English
  • Français

The Pursuit of Excellence in Acute Stroke Care

Published online by Cambridge University Press:  02 December 2014

Brian Silver
Brian Silver*
Affiliation:
Detroit, Michigan, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 32 , Issue 4 , November 2005 , pp. 401 - 402
Copyright
Copyright © The Canadian Journal of Neurological 2005

References

1. Canadian Stroke Network. Descriptive analysis of tPAuse for strokein phase 1 and 2 of the registry of the Canadian Stroke Network. Can J Neurol Sci 2005;32 (In print)Google Scholar
2. Katzan, IL, Furlan, AJ, Lloyd, LE, et al. Use of tissue-typeplasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283:1151–1158.Google Scholar
3. Riopelle, RJ, Howse, DC, Bolton, C, et al. Regional access to acuteischemic stroke intervention. Stroke 2001;32:652–655.Google Scholar
4. Merino, JG, Silver, B, Wong, E, et al. Extending tissue plasminogenactivator use to community and rural stroke patients. Stroke 2002;33:141–146.Google Scholar
5. Grotta, JC, Burgin, WS, El-Mitwalli, A, et al. Intravenous tissue-typeplasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001;58:2009–2013.Google Scholar
6. Saposnik, G, Young, B, Silver, B, et al. Lack of improvement inpatients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA 2004;292:1839–1844.Google Scholar
7. Alberts, MJ, Hademenos, G, Latchaw, RE, et al. Recommendationsfor the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000;283:3102–3109.CrossRefGoogle Scholar
8. The Heart and Stroke Foundation of Canada and the CanadianStroke Society. Stroke Treatment Education Program. 1999; http://209.5.25.171/ClientImages/1/CSSSTEP.pdf (accessed 5-20-05)Google Scholar
9. Adams, HP Jr, Brott, TG, Furlan, AJ, et al. Guidelines forThrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 1996;27:1711–1718.Google Scholar
10. Chapman, KM, Woolfenden, AR, Graeb, D, et al. Intravenous tissueplasminogen activator for acute ischemic stroke: A Canadianhospital's experience. Stroke 2000;31:2920–2924.Google Scholar
11. Albers, GW, Bates, VE, Clark, WM, et al. Intravenous tissue-typeplasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145–1150.CrossRefGoogle ScholarPubMed
12. Marler, JR, Tilley, BC, Lu, M, et al. Early stroke treatment associatedwith better outcome: the NINDS rt-PA stroke study. Neurology 2000;55:1649–1655.CrossRefGoogle Scholar
13. Tanne, D, Bates, VE, Verro, P, et al. Initial clinical experience with IVtissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology 1999;53:424–427.Google Scholar
14. Hacke, W, Donnan, G, Fieschi, C, et al. Association of outcome withearly stroke treatment: pooled analysis of ATLANTIS, ECASS,and NINDS rt-PA stroke trials. Lancet 2004;363:768–774.Google Scholar
15. Adams, H, Adams, R, Del Zoppo, G, Goldstein, LB. Guidelines for theearly management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36:916–923.Google Scholar
16. Tu, JV, Willison, DJ, Silver, FL, et al. Impracticability of informedconsent in the Registry of the Canadian Stroke Network. N Engl J Med 2004;350:1414–1421.Google Scholar
17. Hill, MD, Buchan, AM. Thrombolysis for acute ischemic stroke:results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005;172:1307–1312.Google Scholar